-
rTMS Restores Cognition Through GABAergic Signaling
2026-09-28
A 2025 study in 5xFAD mice links repetitive transcranial magnetic stimulation (rTMS) to increased Cx3cl1 signaling in GABAergic neurons, stronger microglial phagocytic activity, lower amyloid plaque burden, and cognitive recovery. The findings offer a cellular framework for studying non-invasive stimulation in Alzheimer’s disease, while leaving stimulation parameters and the pathway’s causal requirements important questions for further testing.
-
Dacomitinib Workflows for ErbB Cancer Research
2026-09-27
Use Dacomitinib (PF-00299804) to test how durable pan-ErbB inhibition changes receptor signaling, proliferation, and cell fate in responsive or resistant cancer models. A separate, carefully controlled workflow can examine METTL17-linked ferroptosis biology without mistaking an association for a proven drug mechanism.
-
HyperScribe SP6 Kit for Mechanistic RNA Assays
2026-09-26
The HyperScribe SP6 High Yield RNA Synthesis Kit can support carefully controlled RNA probe and transcript workflows. This article connects its practical uses to a SARS-CoV-2 study of GADD34 RNA sequestration, with a focus on assay design, interpretation, and limits.
-
Z-VDVAD-FMK for Apoptosis Assay Design
2026-09-25
Z-VDVAD-FMK helps researchers probe caspase-2-linked apoptosis and mitochondrial signaling, while its activity against caspases-3 and -7 calls for careful interpretation. In HOXC8-depleted lung cancer models, it is best used as a pathway-dissection comparator—not as a caspase-1 inhibitor or a stand-alone test for pyroptosis.
-
Fingolimod (FTY720): Assays, Workflows & Optimization
2026-09-25
Fingolimod (FTY720) helps researchers probe S1P-linked lymphocyte trafficking, CNS-associated BDNF and ERK responses, and dose-dependent effects on cancer cells. This workflow guide also explains why it may be a useful trafficking-control variable—but not an established combination partner—in emerging in vivo CAR-T-mimicking studies.
-
MK 0893: Workflows for GCGR Signaling Studies
2026-09-24
Use MK 0893 to probe glucagon receptor signaling with a practical, concentration-guided workflow for cAMP assays and metabolic studies. The article separates product performance data from proposed assay starting conditions and explains how to troubleshoot potency, solvent, and receptor-specificity issues.
-
15-PGDH Inhibition and Muscle Repair During Weight Loss
2026-09-24
A 2026 PNAS study reports that inhibiting 15-PGDH can improve muscle stem-cell activity, regenerated fiber growth, and strength recovery in semaglutide-treated obese mice, without eliminating semaglutide-associated weight loss. The findings identify a potential way to study muscle quality during pharmacological weight reduction, while leaving important questions about dose, long-term effects, and human relevance unresolved.
-
SW033291 Workflows for 15-PGDH Research
2026-09-23
Use SW033291 to test how blocking prostaglandin breakdown affects PGE2 signaling, hematopoietic recovery, and tissue repair. A practical workflow connects enzyme and cell assays to emerging muscle-regeneration findings while separating evidence from assay-development recommendations.
-
2-Hydroxypropyl-β-cyclodextrin: Solubility Guide
2026-09-23
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to screen and improve the apparent aqueous solubility of poorly water-soluble research compounds, particularly molecules with aromatic or phenyl-containing regions. It is appropriate for pharmaceutical and biochemical solubility workflows and drug formulation excipient evaluation, but the supplied evidence does not establish compound-specific pharmacokinetics, clinical benefit, or applications outside solubility-focused research.
-
Sisomicin: Practical Workflows for Antibacterial Research
2026-09-22
Build reproducible Sisomicin assays for resistant Gram-negative and Gram-positive research models, from MIC screening through persister-focused follow-up. A reference-inspired microbroth workflow, comparative controls, and troubleshooting guidance help distinguish true antibacterial activity from solvent, inoculum, and endpoint artifacts.
-
ATP Solution (100 mM) for Assay Reliability
2026-09-22
A scenario-driven guide to using ATP Solution (100 mM), SKU K1043, in kinase, transcription, ligation, phosphorylation, and mRNA-LNP research workflows. It separates ATP reagent quality from direct cell-viability readouts and translates product specifications into practical handling and interpretation controls.
-
PA-824: A Bicyclic Nitroimidazole for TB Research
2026-09-21
PA-824 is a high-potency tuberculosis research compound for probing cell-wall biosynthesis, nitric oxide release, and respiratory vulnerability in Mycobacterium tuberculosis. This practical guide converts its dual-action biology into reproducible susceptibility, persistence, and combination-assay workflows, with troubleshooting for solubility, controls, and signal interpretation.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-21
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve handling of poorly water-soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. It is appropriate as a drug formulation excipient and solubility-enhancement reagent in pharmaceutical or biochemical workflows, but the supplied record does not establish therapeutic efficacy or unrelated applications.
-
Homoharringtonine: Assay Design from Ribosome to Virus
2026-09-20
Homoharringtonine is a cytotoxic alkaloid whose ribosome-targeting activity connects leukemia research with SARS-CoV-2 antiviral research. This guide focuses on assay architecture, endpoint selection, and the practical limits of translating protein-synthesis inhibition across disease models.
-
Caspase-4 Colorimetric Assay Kit: Practical Guide
2026-09-19
Turn pyroptosis and inflammatory signaling questions into quantitative LEVD-dependent caspase-4 measurements with a rapid colorimetric workflow. This guide connects the assay to ER-stress cancer models while emphasizing controls, normalization, and interpretation limits.